All Stories

  1. Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges
  2. Interspecies Allometric Scaling of Antimalarial Drugs and Potential Application to Pediatric Dosing
  3. Pharmacokinetics and safety of deferasirox in subjects with chronic kidney disease undergoing haemodialysis
  4. Simultaneous determination of primaquine and carboxyprimaquine in plasma using solid phase extraction and LC–MS assay
  5. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives
  6. Pharmacokinetics, Pharmacodynamics, and Allometric Scaling of Chloroquine in a Murine Malaria Model
  7. Improving the solubility and bioavailability of dihydroartemisinin by solid dispersions and inclusion complexes
  8. Investigation of reproductive toxicity of piperaquine in mice
  9. Toxicology and pharmacokinetics of piperaquine in mice
  10. Plasmodium berghei: Parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model
  11. Development of a pharmacodynamic model of murine malaria and antimalarial treatment with dihydroartemisinin
  12. Pharmacokinetics and Pharmacodynamics of Piperaquine in a Murine Malaria Model
  13. Pharmacokinetics and Efficacy of Piperaquine and Chloroquine in Melanesian Children with Uncomplicated Malaria
  14. Comparison of gentamicin dose estimates derived from manual calculations, the Australian ‘Therapeutic Guidelines: Antibiotic’ nomogram and the SeBA‐GEN and DoseCalc software programs
  15. Adverse drug reaction reporting in Australian hospitals
  16. Domiciliary medication reviews by fourth year pharmacy students in Western Australia
  17. Hepatocellular bioactivation and cytotoxicity of the synthetic endoperoxide antimalarial arteflene
  18. Protein binding and α : β anomer ratio of dihydroartemisinin in vivo
  19. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea
  20. A randomised controlled trial of a pharmaceutical care programme in high-risk diabetic patients in an outpatient clinic
  21. The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malaria
  22. Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
  23. Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate in Severe Falciparum Malaria
  24. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes
  25. A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria
  26. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double‐blind, placebo‐controlled trial
  27. Selective high-performance liquid chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria
  28. Chemical Stability of Artesunate Injection and Proposal for its Administration by Intravenous Infusion
  29. The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.
  30. NSAID prescribing information